NeurAxis (NRXS) Projected to Announce Earnings on Monday

NeurAxis (NASDAQ:NRXS) will likely be releasing its results before the market opens on Monday, November 9th. Analysts expect NeurAxis to post earnings of ($0.21) per share and revenue of $2.10 million for the quarter.

NeurAxis Stock Performance

Shares of NRXS stock opened at $7.13 on Monday. NeurAxis has a fifty-two week low of $2.21 and a fifty-two week high of $9.33. The stock has a 50 day moving average price of $6.83 and a two-hundred day moving average price of $6.63. The company has a market capitalization of $89.54 million, a P/E ratio of -3.87 and a beta of 1.38.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of NeurAxis to a “hold” rating in a research report on Friday, October 2nd. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $13.00.

About NeurAxis

NeurAxis, Inc (NASDAQ: NRXS) is a medical technology company focused on developing and commercializing non-invasive neuromodulation therapies for functional gastrointestinal and other nervous-system-related disorders. The company’s approach is designed to influence neural signaling through targeted electrical stimulation.

NeurAxis’s principal product is IB-Stim, a prescription, percutaneous electrical nerve-field stimulation device intended for use in adolescents with functional abdominal pain associated with irritable bowel syndrome and related functional gastrointestinal disorders.